We report an unusual and severe vasculitic disorder following co-trimoxazole, given orally for a urinary tract infection. The vasculitis was manifest solely as thrombophlebitis migrans and involving only veins without evidence of polyarteritis nodosa, or underlying malignancy.
Introduction
Since the introduction of co-trimoxazole, a combination of trimethoprim and sulphamethoxazole, in 1968, numerous While the steroid dose was being reduced, he returned to Cyprus, where a doctor advised him to abruptly cease his steroids and go on a diet of grape juice. He had a profound relapse with generalized venous involvement, fever and profound weight loss. On return to this country, 4 months after his initial presentation, he was re-admitted. The findings were similar to the initial admission, but on this occasion the thrombophlebitis was relatively resistant to steroids, and addition of cyclosporin conferred no therapeutic benefit. He remained unwell with intermittent fever, erythematous skin rashes and thrombophlebitis mainly ofthe arms until intravenous cyclophosphamide, 200 mg intravenously on alternate days for 5 doses, was administered. This produced a rapid resolution in symptoms, decline in ESR and rise in haemoglobin. He has since been commenced on maintenance cyclophosphamide, and steroids. At no time has there been hypertension or evidence of renal involvement, although his chest X-ray has shown evanescent interstitial shadowing at times of high fever, but no changes of infarction or infection. Computed tomographic scan of the lungs was unhelpful.
Discussion
Skin reactions to co-trimoxazole have been welldocumented, and in one survey2 were found to be the most frequent adverse reaction (3.3%) found in a population of 1,121 patients studied in the Boston Collaborative Drug Surveillance Programme. Vasculitis appears rare. In a case reported in 1976, Wahlin & Rosman3 describe a 69 year old male with a nodular cutaneous vasculitis, confirmed on biopsy to be affecting the small vessels of the dermis. This developed 4 days after commencing oral co-trimoxazole, and was accompanied by fever, leucocytosis and a raised ESR. However, in contrast to the case we report here, the skin lesions and fever resolved spontaneously over 3 weeks. These authors also state that they had observed seven other similar cases, although no clinical details are given of the remaining cases. The total number of reports to the Committee on Safety of Medicines in which vascular problems are mentioned is ten. Of these, one report relates to a deep venous thrombosis, one to superficial thrombophlebitis, although it is not clear whether this was related to intravenous cotrimoxazole, and two cases of thrombophlebitis of the leg.
Sulphonamides have previously been incriminated in the genesis of polyarteritis nodosa, but review of the Committee on Safety of Medicines' data does not support this strongly. Symmers suggests that polyarteritis has become rarer as a pathological entity as the usage of sulphonamides has decreased and that of penicillins has increased.4 He also notes that generalized angiitis may very rarely occur with penicillin, thiouracils, phenylbutazone, quinidine, promazine and hydantoins. He reviews eight cases of 'collagen diseases' associated with drugs, and of these, four were related to sulphonamide usage, two with polyarteritis (one death) on biopsy, and two with thrombotic purpura, although there were no features of angiitis as such in these latter two cases. An earlier paper by van Rijssel & Meyler,5 discusses seven patients, although two are very poorly documented, in whom sulphonamide treatment led to a necrotizing vasculitis, but in all of these cases nephritis was a feature, and polyneuritis was present in 6 of the 7.
Our case had no evidence of nephritis, and the serum creatinine clearance remained normal throughout. The later chest X-ray changes were not accompanied by any respiratory symptoms, nor was the gas transfer factor deranged. There were no signs of polyneuritis, even when the thrombophlebitis was most active. There were no biopsy features suggestive of polyarteritis, and we conclude that this severe generalized thrombophlebitis was an unusual reaction to co-trimoxazole, as it developed within a week of commencing the drug in an otherwise healthy man.
